BMT CTN Protocol 1101

A Multi-Center, Phase III, Randomized Trial of Reduced Intensity(RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (Haplo) for Patients with Hematologic Malignancies

            Protocol Co-Chair: Ephraim Fuchs, MD (410-955-8143) fuchsep@jhmi.edu

            Protocol Co-Chair: Paul O’Donnell, MD, PhD (206-667-1968) podonnel@fhcrc.org

            Protocol Co-Chair: Claudio Brunstein, MD (612-625-3918) bruns072@umn.edu

            Protocol Officer: Mary Eapen, MD  (414-805-0700) meapen@mcw.edu

            Protocol Coordinator: Kate Barowski (301-251-1161) kbarowski@emmes.com

            Medical Monitor: Angie Smith smith719@umn.edu

        

           

The BMT CTN is committed to including widespread transplant community participation in these trials. However, due to the limited resources, not all requests can be accommodated for each protocol. If your center is interested in participating, please fax the completed Affiliate Center Application, or you may complete the short form if currently participating as an affiliate center in any other BMT CTN trial, to BMT CTN DCC/EMMES at 301-251-1355